Try our Advanced Search for more refined results
Connecticut et al v. Aurobindo Pharma USA, Inc. et al
Case Number:
3:16-cv-02056
Court:
Nature of Suit:
Judge:
Firms
- Arnold & Porter
- Baker Botts
- Buchanan Ingersoll
- Clifford Chance
- Day Pitney
- Dechert LLP
- Duane Morris
- Foley & Lardner
- Gibson Dunn
- Greenberg Traurig
- Hogan Lovells
- Kasowitz Benson
- K&L Gates
- Morgan Lewis
- Morrison Foerster
- O'Toole & O'Toole
- Patterson Belknap
- Proskauer Rose
- Pullman & Comley
- Reed Smith
- Shipman & Goodwin
- Wiggin & Dana
- Williams & Connolly
- WilmerHale
- Wilson Sonsini
Companies
- Allergan PLC
- Ascend Laboratories LLC
- Aurobindo Pharma Ltd.
- Avet Pharmaceuticals Inc.
- Dr. Reddy's Laboratories Ltd.
- Emcure Pharmaceuticals Ltd.
- Glenmark Pharmaceuticals Ltd.
- Lannett Company, Inc
- Sandoz International GmbH
- Sun Pharmaceutical Industries Ltd.
- Teva Pharmaceutical Industries Ltd.
- Viatris Inc.
- Zydus Pharmaceuticals Inc.
Government Agencies
- Commonwealth of Kentucky
- Commonwealth of Massachusetts
- State of Indiana
- State of Maryland
- State of Michigan
- State of Nevada
- State of Tennessee
- U.S. District Court for the District of Columbia
Sectors & Industries:
-
July 22, 2024
Price-Fixing Claims Against Par Pharma On Chopping Block
A Connecticut federal judge has asked a coalition of states to explain why he shouldn't toss two price-fixing lawsuits against Par Pharmaceutical Companies Inc., noting that the defendant and its parent, Endo International PLC, recently filed Chapter 11 reorganization plans shielding them from the cases.
-
July 01, 2024
State AGs Get Stay Lifted In Generic Drug Pricing Litigation
A Connecticut federal judge on Monday agreed to lift a partial discovery stay in a trio of generic drug pricing antitrust suits led by the attorneys general of New York and Connecticut, according to a short, text-only order posted to each of the case dockets.
-
June 27, 2024
State AGs Want Stay Lifted In Generic Drug Pricing Suit
The attorneys general of New York and Connecticut have asked a federal judge to lift a partial discovery stay in three state-led generic drug pricing lawsuits against the pharmaceutical industry, saying it is no longer necessary because sentencing is complete in a parallel U.S. Department of Justice proceeding.
-
June 03, 2024
Drug Cos. Can Depose DC AG In Drug Price-Fixing Row
A Connecticut federal judge reluctantly ordered the District of Columbia Attorney General's Office to be deposed by the drug companies wrapped up in more than 40 states' claims over an alleged price-fixing conspiracy, noting that he would not have done so but for the case being remanded from a sprawling multidistrict litigation in Pennsylvania.
-
April 25, 2024
Conn. Judge In Drug Price-Fixing Suit Reveals Day Pitney Ties
U.S. District Judge Michael P. Shea of the District of Connecticut said Thursday he will not recuse himself from overseeing state enforcers' price-fixing claims against Sandoz Inc. and other drug companies despite Sandoz's attorneys being from Day Pitney LLP, where he was once a partner.
-
February 01, 2024
State-Led Generic Drug Cases Removed From MDL
The Judicial Panel on Multidistrict Litigation has sent a trio of cases from state-level enforcers back to federal court in Connecticut, separating them from the sprawling MDL centralized in Pennsylvania over claims of price fixing in the generic drug industry.
-
May 23, 2017
40 States Defend Power To Bring Generic-Drug Price-Fix Suit
Forty states on Monday defended their lawsuit against six generic-drug manufacturers alleging they divided the market and fixed the price of an antibiotic and a diabetes treatment, saying they have the authority to seek an injunction and monetary relief under federal antitrust law.
-
May 03, 2017
Generic-Drug Makers Want 40-State Price-Fix Suit Dropped
Six generic-drug makers accused of conspiring to fix the prices of an antibiotic and a diabetes medication have asked a Connecticut federal court to toss the suit now joined by 40 states, saying the complaint contains a multitude of legal flaws.
-
March 01, 2017
20 More States Join Generic Drug-Pricing Antitrust Action
Forty states are now bringing antitrust claims against six generic-drug makers including Heritage, Mylan and Teva, alleging they conspired to fix the prices of an antibiotic and a diabetes medication, according to an amended complaint filed in Connecticut federal court Wednesday.
-
February 09, 2017
Feds Look To Intervene In 20-State Drug Antitrust Suit
The U.S. government on Thursday asked a Connecticut federal court for permission to intervene in an antitrust action from 20 states against six generic-drug makers including Heritage, Mylan and Teva, citing the need to "protect the integrity" of its own investigation into the generic pharmaceutical industry.
- ← Previous
- 1
- 2
- 3
- Next →